Research Identifies a Potential Link Between Sleep Apnea and Memory Loss
Breastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development
Exploring the Clinical Treatments of Schizophrenia
Ashley Baker, MSN, PMHNP
Nabil Ali, MD
The Role of Occupational Therapy in Schizophrenia Management
Lauren Walker, OT
Investigating the Prevalence of Comorbidities in MS Clinical Trials
Amber Salter, PhD
New Frontiers in Optimizing Patient Outcomes in Multiple Sclerosis: Strategies for Early Intervention to Address Progression Independent of Relapse
Stephen Krieger, MD
Tirisham Gyang, MD
Augusto Miravalle, MD, FAAN
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Andrew Wilner, MD, FACP, FAAN
Victoria Leavitt, PhD
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
Dejan Jakimovski, MD, PhD
The Alarming Shortage of ADHD Medication and Its Implications on Patients
Understanding the Cellular Basis for Altered Cognition in Schizophrenia
Samuel Dienel, PhD
Practices for Preventing Polypharmacy in Multiple Sclerosis
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ahmed Zayed Obeidat, MD, PhD
Lauren Beranek, BS
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
Stanley N. Caroff, MD
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Charles Turck, PharmD, BCPS, BCCCP
Jagan Pillai, MD, PhD
Exploring the Latest in MS Cognitive Rehabilitation Strategies
Nancy Chiaravalloti, PhD
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
Anna Shah, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.